New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
about
Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.Clinical implications of neuroendocrine differentiation in prostate cancer.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.
P2860
New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
New perspective in the managem ...... on in prostate adenocarcinoma.
@ast
New perspective in the managem ...... on in prostate adenocarcinoma.
@en
type
label
New perspective in the managem ...... on in prostate adenocarcinoma.
@ast
New perspective in the managem ...... on in prostate adenocarcinoma.
@en
prefLabel
New perspective in the managem ...... on in prostate adenocarcinoma.
@ast
New perspective in the managem ...... on in prostate adenocarcinoma.
@en
P2093
P1476
New perspective in the managem ...... ion in prostate adenocarcinoma
@en
P2093
Di Monaco F
Di Silverio F
Mariotti G
P304
P356
10.1111/J.1742-1241.2006.00750.X
P577
2006-04-01T00:00:00Z